Our laboratory has previously highlighted the protective benefit of inhibiting the C5a/C5aR1 signaling axis in a murine model of T1DM using PMX53 (Ac-Phe-[Orn-Pro-cha-Trp-Arg]) [44]. Here, C5 is linked to type 1 diabetes mellitus.